chrisvoncsefalvay/vaers-outcomes huggingface dataset:
blood pressure was 200/120; felt like it was hard to breathe; felt dread; felt a strange cold rush over his system; A spontaneous report was received from consumer concerning a 41 years old male patient who received Moderna's COVID-19 vaccine (mRNA-1273) and felt a strange cold rush over his system/ feeling cold, felt like it was hard to breathe/dyspnoea,  felt dread/fear,  blood pressure was 200/120/hypertension.  The patient's medical history was not reported by the reporter. Concomitant medications taken by the patient were not provided.   On 8 Feb 2021, prior to the onset of the event, the patient received their first of two planned doses of mRNA-1273 (Lot number: 013L20A) through intramuscular route at left arm for prophylaxis of COVID-19 infection.   On 8 Feb 2021, less than a minute after receiving vaccine, patient felt a strange cold rush over hissystem felt like it was hard to breathe, he felt dread. Patient reported that the facility had checked and his blood pressure was 200/120. Patient was not sure if it was a panic attack, but he took antianxiety medicine.  Treatment activities for event was done with antianxiety medicine.  The seriousness criteria for the event hypertension was assessed as medically significant.  The seriousness criteria for other event was not reported.  Action taken with mRNA-1273 in response to the events was unknown.  The outcome of events, and felt a strange cold rush over his system, felt like it was hard to breathe, felt dread, blood pressure was 200/120 were unknown.; Reporter's Comments: Based on the information provided which includes a STRONG temporal association between the reported events, administration of mRNA-1273 vaccine and excluded all other etiologies, a causal association cannot be excluded
Severe constant upper abdominal pain; Nausea; This is a spontaneous report from a non-contactable consumer, the patient. A 67-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6202) via an unspecified route of administration in the left arm on 05Mar2021 (at the age of 67-years-old) as a single dose for COVID-19 immunisation. Medical history included known allergies to penicillin. Prior to the vaccination, it was unknown whether the patient was diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included lisinopril (MANUFACTURER UNKNOWN), budesonide, formoterol fumarate (SYMBICORT), atorvastatin (MANUFACTURER UNKNOWN), levothyroxine sodium (SYNTHROID) and metoclopramide hydrochloride (LIOTHYL): all from an unknown date for unspecified indication and unknown if ongoing. The patient previously took codeine (MANUFACTURER UNKNOWN) for unknown indication and experienced drug allergy. On 05Mar2021 at 17:00, the patient experienced severe constant upper abdominal pain and nausea. The events resulted in emergency room/department or urgent care. Therapeutic measures were taken as a result of severe constant upper abdominal pain and nausea and included treatment with unspecified anti-nausea medications (meds) and pain killers. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events severe constant upper abdominal pain and nausea was recovered on unknown date on 2021.  No follow-up attempts are possible. No further information is expected.
Severe dizziness; This is a spontaneous report from a contactable Physician reporting for herself.  A 61-years-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/lot number: EH9899), via an unspecified route of administration on 18Dec2020 at single dose for covid-19 immunisation. Medical history was none. There were no concomitant medications. The patient experienced severe dizziness on 18Dec2020 with outcome of recovering. No treatment was performed. The patient underwent CMP test on 07Dec2020 and it was normal.
Arm was sore. Soreness did not go away as expected, but worsened. It moved up into my shoulder. Eventually the pain was constant and increased with movement. I lost motion in my arm. I went to an orthopedist on 8/23/21. She seemed skeptical that the injury was related to the vaccine and refused to examine the area. She did a series of shoulder xrays and diagnosed me with rotator cuff tendinitis and gave me a cortisone injection. Her treatment made my condition worse. I saw a second orthopedist on 9/30/21. He diagnosed me with frozen shoulder related to covid vaccine. He gave me a cortisone injection in a different location and prescribed physical therapy. My pain has improved somewhat with his treatment, however, I still do not have range of motion.
High fever 103.7 Headache  Chills Sweating Body aches All lasted 24 hours  Fatigue -5 days
This spontaneous report was received from a registered nurse and refers to a patient of unknown age and gender. The patient's concurrent conditions and medical history were not reported. On 22-JUN-2016, the patient was vaccinated with improperly stored dose of MMR II 0.5 ml injection, lot# L032181, expiry date: 25-AUG-2017 (route and site of administration were not reported). Concomitant therapies were not provided. According to the reporter, the vaccine was stored at a temperature of 11.1 degrees Celsius for 1 hour and 36 minutes and also at a temperature of -12.3 degrees Celsius for 1 hour and 33 minutes (excursion dates were not reported). No adverse symptoms  were reported. No product quality complaint (PQC) was involved. This is one of several reports received from the same reporter. Additional information has been requested.
Sickness. Constant screaming. Bowing of the body. Breaking out in whelps and hives.
I got my period a few hours after vaccination,  around 7 days earlier than usually. Starting from the day of vaccination, every other cycle, I get my period 7 days ahead of schedule.  I would like to emphasize that since the past 30 years my period had been very regular. Usually my cycle lasted 29-32 days.   In addition,  my friend, who got a vaccine with me, also experienced very similar disturbance in her period.
got hives; This spontaneous case was reported by a pharmacist and describes the occurrence of URTICARIA (got hives) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 prophylaxis.     No Medical History information was reported. In March 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In 2021, the patient experienced URTICARIA (got hives). At the time of the report, URTICARIA (got hives) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. The patient was given dose 1 of Moderna vaccine in March, got hives, so they HCP) didn't recommend continuing with Moderna. No Concomitant medications were reported. No treatment medications were reported.  This case was identified as part of a retrospective clean-up activity where certain emails received in the Moderna mailbox were missed to be booked-in.
Received chicken pox vax on 06/30/1999. Mother called today and said patient broke out thise AM. Poxes on abd, back, buttocks, legs, and arms. Mother contacted her daughter. Mother does not know of anyone patient has been in contact with that has had chicken pox.
late Saturday, headache, buzzing in head, doctor Monday steroid shot, Thursday night buzzing in head again soreness of shoulder
Reports felt sharp pain at the time of the injection  which radiated to her wrist /hand.  20 minutes later during her Physical Therapy session, while lying on the table during a massage she felt body wide pain, described as sharp pain and her muscles were rigid, she could not get up off the table.  After 20 minutes of this; her  Physical Therapist was able to assist her off the bed, to  standing/walking,  she felt very stiff, difficulty flexing her muscles.   Also,  had a headache that she described was very painful; that evening she had fever and fatigue.  Symptoms lasted approximately 4-5 days.  She did not seek medical attention, other than the PT at the onset of  her symptoms .    Three weeks later her  toddler "head butted" and  hit her right arm at the site wear vaccine was given.  Reports very sharp and  profound pain,  "felt exactly as it did when I first got the injection"  The pain took a couple days to resolve.  Today 4 weeks later she reports still having  some swelling/soft tissue lump at the injection site.  Negative for redness, warmth.  She did not seek medical care or call the clinic to report adverse events.  She attempted to file a VAERS report but was unsuccessful as she did not have her vaccine lot number.
Information has been received from a licensed practical nurse concerning an approximately 8 year old patient who on 23-SEP-1998 was vaccinated with a dose of VARIVAX (Merck) (lot#631072/0449J). On approximately 06-FEB-2007, the patient developed varicella. At the time of the report, the patients' outcome was unknown. This is one of several reports received from the same source. No further information is available.
hand tingling, sweating Narrative:  Developed intermittent bilateral hand tingling, lasting about 3-4 seconds initially about 30 minutes after vaccination. Over next 2 hours, experienced this 2-3 more times. Not painful, no associated swelling, no s/sx of angioedema or anaphylaxis. Experienced 2 hours of increased cold sweat after vaccination. Was nervous/anxious prior to vaccination and had feelings of continued anxiety during this time period. Has a history of syncope after blood draws related to anxiety, but states no prior reaction to vaccinations. Denied any other adverse effects. Notes having minimally dry/sore throat the next day that resolved spontaneously and lasted less than an hour.
seizure; This spontaneous case was reported by a consumer and describes the occurrence of SEIZURE (seizure) in a 47-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037B21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history).    On 11-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Apr-2021, the patient experienced SEIZURE (seizure) (seriousness criterion medically significant). At the time of the report, SEIZURE (seizure) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were reported. Treatment information was not provided.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of this event, a causal relationship cannot be excluded.
W/IN 3 DAYS, RED, SWELLING & INFLAMMATION ~ 3" DIAMETER PT CAME AFTER 7 DAYS, SIZE INCREASED TO 8-12". HAD TRIED ICE, HYDROCORTISONE & ADVIL.
Sore vaccination arm; Fever; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore vaccination arm) and PYREXIA (Fever) in a 60-year-old female patient who received mRNA-1273 (Spikevax) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Sore vaccination arm) and PYREXIA (Fever). At the time of the report, PAIN IN EXTREMITY (Sore vaccination arm) and PYREXIA (Fever) outcome was unknown.            No concomitant medication was provided  Treatment information was not provided.   This case was linked to MOD-2022-522832 (Patient Link).
pt devel an inj site rxn characterized by a 10cm area of erythema, warmth, & pruritus p/vax; this is 1 of 4 pt from this site to devel an inj site rxn p/vax;
Received vaccine at 1:00 pm on 29th; woke up at 4:45 am on 30th with nausea, vomiting, diarrhea (similar to food poisoning, violent and crampy, miserable), headache, muscle aches and weakness.  This went on every 20-30 minutes for a few hours before it began to improve; I took 4 Immodium and 2 Tylenol.  I could not eat the rest of the day.  On October 1st, I felt better, and on October 2nd I felt pretty good, although still with muscle aches bad enough that I did not exercise.
No adverse event; Interval between First and second primary doses was too short.Patient: Received first primary dose on 03Jun2022 and the second dose on 22Jun2022/ 3rd primary dose on 03Aug2022; This spontaneous case was reported by a consumer and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Interval between First and second primary doses was too short.Patient: Received first primary dose on 03Jun2022 and the second dose on 22Jun2022/ 3rd primary dose on 03Aug2022) and NO ADVERSE EVENT (No adverse event) in a  patient of an unknown age and gender who received mRNA-1273 (Spikevax) (batch no. ASKU) for COVID-19 prophylaxis.     No Medical History information was reported.    On 22-Jun-2022, the patient received second dose of mRNA-1273 (Spikevax) (Intramuscular) 1 dosage form. On 22-Jun-2022, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Interval between First and second primary doses was too short.Patient: Received first primary dose on 03Jun2022 and the second dose on 22Jun2022/ 3rd primary dose on 03Aug2022). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Interval between First and second primary doses was too short.Patient: Received first primary dose on 03Jun2022 and the second dose on 22Jun2022/ 3rd primary dose on 03Aug2022) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Spikevax) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Interval between First and second primary doses was too short.Patient: Received first primary dose on 03Jun2022 and the second dose on 22Jun2022/ 3rd primary dose on 03Aug2022).    No concomitant medications were reported. No treatment information was provided.
Shingles after having had the full vaccine.; Shingles; This case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Co-suspect products included Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 2nd dose of Shingles vaccine and the 1st dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine and Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine and Shingles vaccine.     Additional Information: GSK Receipt Date: 16th Apr 2022 Reporter's Comments: This case was reported by a consumer via interactive digital media. The case was reported by patient. The patient reported that he/she contracted shingles after having full vaccination. Additional Supportive Information: This case was considered as suspected vaccination failure since details regarding time to onset and laboratory confirmation of shingles not given. The follow up would not be possible since no contact details provided.
Positive covid PCR test; the patient had 2 additional PCR tests with negative results. This has been dismissed a false positive; mild symptoms; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP).  A 12 year-old male patient received bnt162b2 (BNT162B2), administration date Sep2021 (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose Number: 1, Batch/Lot No: Unknown. Not available/provided to reporter at the time of report completion), administration date: Sep2021, when the patient was 12 years old, for Covid-19 immunization. The following information was reported: SARS-COV-2 TEST FALSE POSITIVE (non-serious) with onset Nov2021, outcome "recovered", described as "Positive covid PCR test; the patient had 2 additional PCR tests with negative results. This has been dismissed a false positive"; COGNITIVE DISORDER (non-serious) with onset Nov2021, outcome "recovered", described as "mild symptoms". Relevant laboratory tests and procedures are available in the appropriate section.  Additional Information: : Positive covid PCR test with mild symptoms within a short time from vaccination - since the discovery of this information, the patient had 2 additional PCR tests with negative results. This has been dismissed as false positive (and only mild symptoms). Covid tested post vaccination: covid test date=Nov2021, covid test result=Inconclusive.  No follow-up attempts are possible. No further information is expected.
Pt recv vax on 9/1/98; on unspecified date pt exp  "TD reaction".
After months patient received the Moderna vac and got really sick both times; This spontaneous case was reported by an other health care professional and describes the occurrence of ILLNESS (After months patient received the Moderna vac and got really sick both times) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included COVID-19 (Patient had a severe case of COVID).    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ILLNESS (After months patient received the Moderna vac and got really sick both times). At the time of the report, ILLNESS (After months patient received the Moderna vac and got really sick both times) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported.  Treatment information was not provided.   This case was linked to MOD-2021-411091 (Patient Link).
24 hours post vaccination, started with blotchy rash to back of neck and ankles, was given BENADRYL and woke in AM of 10/01/2009 with rash that was raised welts, whitish extending onto face and  head. Diagnosed as urticaria.
Information has been received from a registered nurse concerning a 65 year old (also reported as 64 year old) female with hypertension, gastrooesophageal reflux disease (GERD), a history of anaemia, and allergies to Benadryl, DEMEROL, SUPRAX, NAPROSYN, IMITREX, SOMA who on 27-APR-2009 was subcutaneously vaccinated with 0.65 ml dose of ZOSTAVAX (Merck) (lot #663883/0132Y). Concomitant therapy included PROTONIX, HCTZ, NEURONTIN, RHINOCORT budesonide, SYMBICORT and montelukast sodium (MSD). On 01-MAY-2009 the patient developed injection site rash after receiving ZOSTAVAX (Merck). The rash was red, itchy and swollen. The patient did not recover at time of reporting. The patient called the practice for medical attention. Additional information has been requested.
c/o T 103.6, nausea, diarrhea, head-toe rash. MD states they were all rxns to DTP/MMR/HIB/TOPV given 1 wk ago
Upon waking the morning after vaccination, patient discovered the injection site was raised about 1.5 inches, red, and warm to the touch within a four inch diameter surrounding deltoid. The exact injection site had a "white dot." The area has slowly started to return to normal but is still somewhat raised, red, and warm to the touch (4 days post injection). Patient also experienced muscle aches and chills throughout entire body for 24 hours. Patient experienced a low-grade fever (Max: 99 degrees) during the morning of 10/26/2021, resolved by afternoon.
phantosmia Narrative:  reported the adverse reaction today 9-16-2022. reports had to leave her work for nausea due to phantom odor
Chills began.  Within an hour of the chills sweating started. By the evening a low grade fever.  Muscle aches since the onset of the adverse reaction. By day two the shot site formed a pink welt about 2-3 inches in diameter.  20 April the welt is 5-6 inches in diameter and the low grade fever continues. Muscle aches since.
Had 1st shot 4/15/21 only experienced sore upper arm.  2nd shot 5/13/21 same arm. Woke the next morning and went to work. (6:45am). By 8am I first started feeling extremely tired and then chills followed by headache and achy.. I excused myself from work and went home. Slept a couple of hours and woke with a temp of 102.2. (I used an infrared thermometer). Took 2 Tylenol and slept for another few hours. By late afternoon my temp spiked to 104.9. Taking another dose of Tylenol and cold compresses it eventually went down and felt relatively normal by Sunday morning.
a sensation of pressure; soreness; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE DISCOMFORT (a sensation of pressure) and VACCINATION SITE PAIN (soreness) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Irritable bowel syndrome (IBS-D ( diarrhoea )).    On 14-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Apr-2021, the patient experienced VACCINATION SITE DISCOMFORT (a sensation of pressure) and VACCINATION SITE PAIN (soreness). On 15-Apr-2021, VACCINATION SITE DISCOMFORT (a sensation of pressure) and VACCINATION SITE PAIN (soreness) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Most recent FOLLOW-UP information incorporated above includes: On 31-May-2021: Updated the outcome of the events from unknown to recovered.
Office drew up all doses from a vial and discarded w/o a double check. They used a sticky note w/the bivalent NDC, lot and exp date as source of data for EMR. At some point they realized that on some days they had administered monovalent vaccine instead of the intended bivalent booster.
Right parotitis- felt to be secondary to MMR vaccine but treated with cefdinir in case of bacterial infection.
Patient reported developing a low-grade temperature within an hour of vaccination followed by burning, moderate pain, and redness at the injection site.  On 07/27/2020, patient reported to pharmacy that there was mild/moderate swelling to the right deltoid region with redness extending to the right lateral elbow with some warmth.  Patient was encouraged to follow-up with her PCP that day to rule out a hyper immune response verses cellulitis.  In a follow-up call to the patient on 07/28/2020, the patient stated that some of the redness that had extended to the elbow had resolved, but there was still warmth/redness/mild-to-moderate pain at the injection site with some extension down the right arm.  She stated that she had called her PCP's office, but that she was not seen the previous day because he was not in the office that day.  Patient was encouraged again to follow-up with her PCP or another clinician in the office as soon as that opportunity was available.